Increased angiogenesis in portal hypertensive rats: Role of nitric oxide

Hepatology

Volumn 29, Issue 4, 1999, Pages 1044-1049

  Sumanovski, Lazar T ^a   Battegay, Edouard ^a   Stumm, Michael ^a   Van Der Kooij, Maaike ^a   Sieber, Cornel C ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

N(G) NITROARGININE; NITRIC OXIDE; PROPRANOLOL;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; NONHUMAN; PORTAL HYPERTENSION; PORTAL VEIN OBSTRUCTION; PRIORITY JOURNAL; RAT; SPLANCHNIC BLOOD FLOW; VASODILATATION;

EID: 0032922414     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510290436     Document Type: Article

References (13)

1. Sikuler E, Kravetz D, Groszmann RJ. Evolution of portal hypertension and mechanisms involved in its maintenance in a rat model. Am J Physiol 1985;248:G618-G625.
2. Groszmann RJ. Vasodilatation and hyperdynamic circulatory state in chronic liver diseases. In: Portal Hypertension. Pathophysiology and Treatment. Bosch J, Groszmann RJ, eds. Oxford: Blackwell Scientific Publications, 1994:17-26.
3. Moncada S, Palmer MJ, Higgs EA. Nitric oxide: physiology, pathology and pharmacology. Pharmacol Rev 1991;43:109-142.
4. Lee FY, Albillos A, Colombato L, Groszmann RJ. The role of nitric oxide in the vascular hyporesponsiveness to methoxamine in portal hypertensive rats. HEPATOLOGY 1992;16:1043-1048.
5. Pizcueta MF, Piqué JM, Bosch J, Whittle BJR, Moncada S. Effects of inhibiting nitric oxide biosynthesis on the systemic and splanchnic circulation of rats with portal hypertension. Br J Pharmacol 1992;105:184-190.
6. Sieber CC, Groszmann RJ. In vitro hyporeactivity to methoxamine in portal hypertensive rats: reversal by nitric oxide blockade. Am J Physiol 1992;262:G996-G1001.
7. Sieber CC, Groszmann RJ. Nitric oxide mediates the in vitro hyporeactivity to vasopressors in mesenteric vessels of portal hypertensive rats. Gastroenterology 1992;103:235-239.
8. Sieber CC, Lopez-Talavera JC, Groszmann RJ. Role of nitric oxide in the in vitro splanchnic vascular hyporeactivity in ascitic cirrhotic rats. Gastroenterology 1993;104:1750-1754.
9. Claria J, Jimenez W, Ros J, Rigol M, Angeli P, Arroyo V, Rivera F, et al. Increased nitric oxide-dependent vasorelaxation in aortic rings of cirrhotic rats with ascites. HEPATOLOGY 1994;20:1615-1621.
10. Tsoporis J, Fields N, Lee RMKW, Leenen FHH. Arterial vasodilation and cardiovascular structural changes in normotensive rats. Am J Physiol 1991;260:H1944-H1952.
11. Lee RMKW, Garfield RE, Forrest JB, Daniel EE. Morphometric study of structural changes in the mesenteric blood vessels of spontaneously hypertensive rats. Blood Vessels 1986;20:57-71.
12. Ziche M, Morbidelli L, Masini E, Amerini S, Granger HJ, Maggi CA, Geppetti P, et al. Nitric oxide mediates angiogenesis in vivo and eridothelial cell growth and migration in vitro promoted by substance P. J Clin Invest 1994;94:2036-2044.
13. Ziche M, Morbidelli L, Choudhuri R, Zhang HT, Donnini S, Granger HJ. Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis. J Clin Invest 1997;99:2625-2634.